The StimRouter Neoromodulation System from Valencia, Calif-based Bioness Inc, as well as the Indego exoskeleton from the Human Motion and Control Business Unit of Parker Hannifin Corp, are finalists in the 2016 Medical Device Excellence Awards (MDEA).

The StimRouter Neuromodulation System is a finalist in the MDEA awards’ Implant and Tissue-Replacement Products category, according to a media release from Bioness.

The Indego exoskeleton is competing in the Rehabilitation and Assistive Device category, per a news release from Parker Hannifin Corp.

Pictured here is a patient wearing an Indego exoskeleton from Parker Hannifin Corp. (Photo courtesy of Parker Hannifin Corp.)

Pictured here is a patient wearing an Indego exoskeleton from Parker Hannifin Corp. (Photo courtesy of Parker Hannifin Corp.)

The competition, which includes 10 different product categories, recognizes products that are commercially available and approved as a medical device either by the FDA or other relevant notified body.

Judging will be based on the following: design and engineering innovations, functional (user-related) innovations, benefit to overall healthcare, benefit to patients, and market differentiation, explains the Bioness news release.

Bronze, Silver, and Gold award winners will be announced June 14 at the Medical Device and Manufacturing (MD&M) East Conference and Exposition in New York City.

For more information, visit Bioness Inc and Parker Hannifin Corp.

[Source(s): Bioness Inc, Parker Hannifin Corp, PR Newswire]